Clinical trial Recruiting at 2 sites Phase 4 Interventional Ages 18 to 65

PRP, PRP with Betamethasone, or Betamethasone Injection for Upper Trapezius Myofascial Pain

Official title: Comparison of Platelet-Rich Plasma, Combined Platelet-Rich Plasma Plus Betamethasone, and Betamethasone Monotherapy Trigger Point Injections in Patients With Upper Trapezius Myofascial Pain Syndrome: A Prospective, Randomized, Assessor-Blind, Controlled Trial

Run by University of Kyrenia · NCT07547605 · Data updated 2026-11-12

Three injectable treatments are tested to see which best reduces pain and helps function for people with upper trapezius myofascial pain.

More Myofascial Trigger Points trials

Quick facts

PhasePhase 4
Study typeInterventional
Ages18 Years to 65 Years
SexAll
Enrollment150 (estimated)
SponsorUniversity of Kyrenia
Academic / other
Locations2 sites (Kyrenia, Keryneia and 1 other locations)
StatusRecruiting
StartedMay 15, 2026
Main results expectedDecember 2026
Study endsJanuary 2027
Registry record updatedJune 16, 2026
Trial IDNCT07547605 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18–65 with upper trapezius myofascial pain syndrome and a single active trigger point who have not responded to at least four weeks of conservative treatment.

Probably not a fit

Participants with multiple trigger points, fibromyalgia, cervical radiculopathy, recent trigger point injections, coagulopathy, or allergies to study injectates may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized, assessor-blinded trial compares three injections for upper trapezius myofascial pain: PRP alone, PRP plus betamethasone, and betamethasone alone. It uses a 3-arm design with equal injection volumes and a single center. Participants are adults aged 18–65 with a history of neck/shoulder pain and a diagnosed active trigger point in the upper trapezius who have not responds to at least four weeks of conservative care. Outcomes are assessed to determine which injection approach provides the greatest relief and functional improvement while avoiding biases related to injection volume. Injection technique is palpation-guided without ultrasound assistance, and outcome assessors are blinded to group assignment.

Why it matters

Potential benefit: If successful, patients may experience greater pain relief and improved function with an optimized injection strategy.

How similar studies have gone: Prior studies have explored PRP and corticosteroid injections separately; this trial tests their combination and compares to corticosteroid alone, a relatively novel combination in this specific condition.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age between 18 and 65 years
* Presentation to the Orthopedics and Traumatology outpatient clinic with neck and/or shoulder pain
* Diagnosis of upper trapezius myofascial pain syndrome based on Simons and Travell criteria, including:
* Presence of a taut band
* Local tenderness
* Referred pain pattern
* Local twitch response
* Presence of a single active trigger point in the upper trapezius muscle
* Symptom duration ≥ 4 weeks
* Pain intensity ≥ 4 on the visual analog scale (VAS)
* Inadequate response to at least 4 weeks of conservative treatment (physical therapy and/or oral analgesics)
* Ability to provide written informed consent

Exclusion Criteria:

* Presence of multiple active trigger points
* Diagnosis of fibromyalgia according to ACR 2010 criteria
* Cervical radiculopathy or myelopathy
* Trigger point injection in the same region within the past 3 months
* Coagulopathy or current anticoagulant or antiplatelet therapy
* Known allergy or contraindication to corticosteroids, local anesthetics, or PRP components
* Active infection (systemic or local)
* Pregnancy or lactation
* Thrombocytopenia (platelet count \< 100,000/µL)
* Malignancy
* Inability to cooperate or provide informed consent

Where it's running

  • Dr. Suat Gunsel University of Kyrenia Hospital
    Kyrenia, Keryneia, Cyprus
    Recruiting
  • Dr. Suat Gunsel University of Kyrenia Hospital
    Kyrenia, Cyprus
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.